Effects of azilsartan in chronik kidney disease with hypertensio
Phase 4
- Conditions
- chronick kidney disease with hypertension
- Registration Number
- JPRN-UMIN000010788
- Lead Sponsor
- Division of Nephrology, Department of Internal medicine, Jichi Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)acute kindey injury 2)severe heart failure 3)type I or type II diabetes mellitus with poor glucose control (serum glycosylated hemoglobin [HbA1c] level > 9%) 4)severe liver dysfunction 5)hyperkalemia (> 5.5 mEq/ml) 6)pregnant women 7)patinets who will not give informed concent 8)patinets who have allegry for azilsartan
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of blood pressure, heart function, renal function
- Secondary Outcome Measures
Name Time Method